ESA Biosimilar Effective for Anemia in Hemodialysis Patients
Researchers found “no clinically meaningful differences” in efficacy and safety between the biosimilar epoetin alfa-epbx and epoetin alfa.
Natasha Persaud
Digital Content Editor https://www.empr.com
Natasha Persaud is digital content editor for Renal & Urology News, part of the Medical Communications Group of Haymarket Media. She holds a BA in English from Barnard College.
